secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0001104659-23-105624
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharmaceuticals amends Series A Preferred Stock redemption and conversion procedures
--------------------------------------------------------------------------------

- Filed Certificate of Amendment to Series A Convertible Preferred Stock with Delaware Secretary of State on Sept 29, 2023.
- Amendment permits additional procedures for payment of redemptions and conversions.
- No change to conversion ratio, dividend rate, or liquidation preference was disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465923105624/0001104659-23-105624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465923105624/tm2327307d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-105624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer